TRAVERE THERAPEUTICS, INC. Unrecognized Tax Benefits, Period Increase (Decrease)
TRAVERE THERAPEUTICS, INC. (TVTX) reported Unrecognized Tax Benefits, Period Increase (Decrease) of -$1.80 million for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2016-11-04
- TRAVERE THERAPEUTICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2016-06-30 was $3.40M.
- TRAVERE THERAPEUTICS, INC. unrecognized tax benefits, period increase (decrease) for the quarter ending 2016-03-31 was $3.00M.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month |
|---|---|---|---|
| 2016-09-30 | -$1.80M 10-Q · filed 2016-11-04 | ||
| 2016-06-30 | $3.40M 10-Q · filed 2016-08-05 | $6.40M derived: sum of 2 quarters · filed 2016-08-05 | |
| 2016-03-31 | $3.00M 10-Q · filed 2016-05-05 | ||
| 2015-09-30 | $400.00K 10-Q · filed 2015-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |